These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30474532)
21. Endothelial cell injury is involved in atherosclerosis and lupus symptoms in gld.apoE Yao G; Qi J; Zhang Z; Huang S; Geng L; Li W; Chen W; Tang X; Wang S; Sun L Int J Rheum Dis; 2019 Mar; 22(3):488-496. PubMed ID: 30575313 [TBL] [Abstract][Full Text] [Related]
22. Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus. Mohan S; Barsalou J; Bradley TJ; Slorach C; Reynolds JA; Hasni S; Thompson B; Ng L; Levy D; Silverman E; Kaplan MJ Arthritis Rheumatol; 2015 May; 67(8):2257-62. PubMed ID: 25891295 [TBL] [Abstract][Full Text] [Related]
23. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Gustafsson JT; Svenungsson E Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980 [TBL] [Abstract][Full Text] [Related]
24. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms. Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765 [TBL] [Abstract][Full Text] [Related]
25. Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients. Mercurio V; Lobasso A; Barbieri L; Parrella P; Ciervo D; Liccardo B; Bonaduce D; Tocchetti CG; De Paulis A; Rossi FW Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052336 [TBL] [Abstract][Full Text] [Related]
26. Disease trends over time and CD4 Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407 [TBL] [Abstract][Full Text] [Related]
27. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls. Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714 [TBL] [Abstract][Full Text] [Related]
28. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis. Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442 [TBL] [Abstract][Full Text] [Related]
29. Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity. Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG Rheumatology (Oxford); 2018 Dec; 57(12):2158-2166. PubMed ID: 30102390 [TBL] [Abstract][Full Text] [Related]
37. The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus. Kahlenberg JM; Kaplan MJ Arthritis Res Ther; 2011 Feb; 13(1):203. PubMed ID: 21371346 [TBL] [Abstract][Full Text] [Related]
38. Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Colombo BM; Murdaca G; Caiti M; Rodriguez G; Grassia L; Rossi E; Indiveri F; Puppo F Ann N Y Acad Sci; 2007 Jun; 1108():121-6. PubMed ID: 17893978 [TBL] [Abstract][Full Text] [Related]
39. Management of cardiovascular disease in patients with systemic lupus erythematosus. Piranavan P; Perl A Expert Opin Pharmacother; 2020 Sep; 21(13):1617-1628. PubMed ID: 32511034 [TBL] [Abstract][Full Text] [Related]